Dr. François QUENET is an expert in digestive and hepatobiliary surgery. In addition to serving as oncology surgeon, runs programs treatment of intraperitoneal hyperthermic peritoneal carcinomatosis by surgery plus chemotherapy (HIPEC). It is the principal investigator of the trial "Prodige 7" (phase III) devoted to research on HIPEC and colorectal cancer. He is a member of the research team INSERM U896, working on "molecular basis of resistance to anti-tumor". Produces publications on a regular basis both nationally and internationally.
*Translated with Google translator. We apologize for any imperfection